Skip to content
Catalyst

menaquinone-7Finding

Menaquinone‑7 decreases serum undercarboxylated osteocalcin concentration

lowersVery limited evidenceFindingreplicated ×2

01 · The sentence it was drawn from

“Serum levels of cOC increased and ucOC decreased in the treatment versus the placebo group (p < 0.001).”
Quoted verbatim from Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.
This finding among the 4 findings on its endpoint

menaquinone-7

Serum undercarboxylated osteocalcin concentration

lowers

Who
Healthy Norwegian women aged 50-60 years, 1-5 years after menopause
Dose studied
360 microg MK-7 in the form of Natto capsules, 12 months (dosing frequency not stated in the abstract); placebo was identical-looking olive-oil capsules

Very limited evidencePMID 19937427 · 2010

02 · The study

Study
RCT
Duration
12 months

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7GK66R3W8ASQ2JFVWCQ8E9V